The drug is being tested in a phase I/II trial, theorized to protect, expand, and improve beta cell health.
Breakthrough T1D launched Project ACT, an initiative to accelerate cell therapies to cure T1D. What are the challenges and potential of this initiative?
Transplanted gene-edited donor cells show 4-week cell survival in established T1D patient without immunosuppression.
13th edition of the annual State of the Cure for Type 1 Diabetes. Summarizing the most impactful news and game-changing developments toward a Practical Cure over the past year.
